Shinji Uemura

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 28, 2019
Benefit-risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers.

Di Bei, Mayu Osawa, Shinji Uemura

Pageof 1

Frequent Collaborators

1 joint publications

Mayumi Hasegawa